Cochrane Abstracts
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion: Cochrane systematic review
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Anti-vascular Endothelial Growth Factor for Macular Oedema Secondary to Central Retinal Vein Occlusion: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435509/all/Anti_vascular_endothelial_growth_factor_for_macular_oedema_secondary_to_central_retinal_vein_occlusion:_Cochrane_systematic_review. Accessed 30 October 2020.
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435509/all/Anti_vascular_endothelial_growth_factor_for_macular_oedema_secondary_to_central_retinal_vein_occlusion:_Cochrane_systematic_review. Accessed October 30, 2020.
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion: Cochrane systematic review. In Cochrane Abstracts Retrieved October 30, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/435509/all/Anti_vascular_endothelial_growth_factor_for_macular_oedema_secondary_to_central_retinal_vein_occlusion:_Cochrane_systematic_review
Anti-vascular Endothelial Growth Factor for Macular Oedema Secondary to Central Retinal Vein Occlusion: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2020 October 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435509/all/Anti_vascular_endothelial_growth_factor_for_macular_oedema_secondary_to_central_retinal_vein_occlusion:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion: Cochrane systematic review
ID - 435509
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435509/all/Anti_vascular_endothelial_growth_factor_for_macular_oedema_secondary_to_central_retinal_vein_occlusion:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
